Senate bill · 119th Congress · Latest step: Introduced
Prescription Drug Supply Chain Pricing Transparency Act
Official title: A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Open in Bill Explorer →Where it went
- IntroducedJan 29, 2026
- Committee action—
- Passed Senate—
- Passed House—
- To the President—
- Became law—
Latest action: Jan 29, 2026 — Read twice and referred to the Committee on Finance.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
1 cosponsor — 1 Republican
1 of 1 cosponsors (100%) are from the other party.
More from the sponsor
Other 119th Congress bills sponsored by Sen. Michael Bennet.
- S. 2754 (119th) Crystal Reservoir Conveyance Act
- S.Res. 585 (119th) A resolution honoring the life, achievements, and legacy of Ben Nighthorse Campbell.
- S.Res. 844 (119th) A resolution honoring the lives and service of Emily Barker, Nicholas Hutcherson, Sydney Watson, Nathan Matthews, Nicholas Dale, and all…
- S.Res. 278 (119th) A resolution condemning the violent antisemitic attack in Boulder, Colorado, and expressing support for the survivors and their families.
- S.Res. 396 (119th) A resolution condemning the tragic act of violence on September 10, 2025, in Evergreen, Colorado, recognizing the victims, survivors, and…
- S.Res. 503 (119th) A resolution recognizing the third commemoration of the anti-LGBTQ+ attack that occurred on November 19-20, 2022, at Club Q, an LGBTQ+ bar…
Sponsor’s state and district
Data as of Sep 13, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.